However, when combined with insulin or sulfonylureas, dose reduction of these agents may be necessary [6]
Frequency: inject 3 times weekly subcutaneously (e.g., Monday/Wednesday/Friday), for a total weekly dose of 1,500 IU
Hinek A, et al
The copper-binding property is not incidental
Current conventional chemotherapeutics, unfortunately, are not specialized for malignant cells and because such therapeutics do not present selective mechanisms to detect normal/abnormal cellular dividing rates, they have severe side effects such as alopecia, vomiting, rashes, and, in some cases, myelosuppression on other cells and organs throughout the body